loader

Addbanner

Dr Stamatina Verykiou

  • 544 view(s)

 


Dr Stamatina Verykiou MD, PhD, MSc, MRCP, SCE (derm)

Dermatologist and Mohs Surgeon Consultant Dermatologist, Royal Victoria Infirmary, UK


 

H Δρ. Βερυκίου αποφοίτησε από το Πανεπιστήμιο της Πάτρας το 2006 και στη συνέχεια μετακόμισε στο Ηνωμένο Βασίλειο για να ολοκληρώσει την μεταπτυχιακή της κατάρτιση. Έχει ολοκληρώσει την βασική ιατρική εκπαίδευση σε διακεκριμένα νοσοκομεία εκπαίδευσης όπως το Royal Marsden hospital και King’s College hospital στο Λονδίνο. Στη συνέχεια μετακόμισε στο Newcastle upon Tyne για να ασκήσει καριέρα ως δερματολόγος μετά από την απόκτηση ενός ανταγωνιστικού κλινικού ακαδημαϊκού προγράμματος στην δερματολογία. Έχει εξασφαλίσει με επιτυχία μια προσωπική υποτροφία από το ίδρυμα Ερευνών Καρκίνου (Cancer Research UK) του Ηνωμένου Βασιλείου για να ολοκληρώσει το διδακτορικό δίπλωμα.

 

Μετά την ολοκλήρωση της δερματολογικής εκπαίδευσής της, ακολούθησε την εξειδίκευση της στην προχωρημένη δερματολογική και χειρουργική δερματο-ογκολογία (Mohs surgery) για την θεραπεία του καρκίνου του δερματος. H Δρ. Βερυκίου ενδιαφέρεται για τη διάγνωση και τη διαχείριση του καρκίνου του δέρματος και έχει επίσης ολοκληρώσει ένα Μεταπτυχιακό στη δερματοσκόπηση και την προληπτική δερματο-ογκολογία από το Πανεπιστήμιο του Graz στην Αυστρία. Έχει δημοσιεύσει πολλά άρθρα σε εθνικά και διεθνή περιοδικά και συμμετέχει σε αρκετά εθνικά και διεθνή συνέδρια. H Δρ. Βερυκίου είναι μέλος της Βρετανικής Ένωσης δερματολόγων (British Association of Dermatologists) και μέλος της επιτροπής της Βρετανικής Οργάνωσης Δερματολογικής Χειρουργικής (British Society for Dermatological Surgery). Αυτή τη στιγμή είναι επιμελήτρια δερματολόγος και δερματοχειρουργός Mohs στο Royal Victoria Infirmary στο Newcastle upon Tyne, Ηνωμένο Βασίλειο και θα μοιράζεται το χρόνο της μεταξύ του Ηνωμένου Βασιλείου και της Κύπρου.


PUBLICATIONS

 

Verykiou S, Edwards N, Hill D.
How breakthroughs in translational research have impacted treatment strategies for melanoma.
Br J Dermatol. 2018 Jan;178(1):5-8. doi: 10.1111/bjd.16112.
Muthiah S, Tang D, Nasr B, Verykiou S.
A new era in holistic care: bridging the gap between dermatologists and oncologists for the treatment of malignant melanoma. Br J Dermatol. 2018 Jan;178(1):1-4.
Verykiou S, Aljefri K, Gopee H, Taheri L, Charlton F, Langtry JA, Blasdale C. (2017)Cutaneous manifestations of phosphate solution extravasation.
Clin Exp Dermatol. 2017 Oct 30. doi: 10.1111/ced.13233
Verykiou S, Goodhead C, Parry G, Meggitt S.
Legionella feeleii: an unusual organism associated with cutaneous infection in an immunocompromised patient. Clin Exp Dermatol. 2018 Apr;43(3):300-302
Wernham AG, Fremlin GA, Verykiou S, Harper N, Chan SA, Stembridge N, Matin RN, Abbott RA. (2016)
Survey of dermatologists demonstrates widely varying approach to perioperative antibiotic use - time for a randomized trial? Br J Dermatol. 2016 Sep 2. doi: 10.1111/bjd.15025
Verykiou S, Oliphant TJ, Rahim R, Husain A, Lawrence CM, Langtry JA.(2016)
Diagnostic biopsy before Mohs micrographic surgery, frequency of change in diagnosis and impact on management. Br J Dermatol. 2016 Mar; 174(3):649-51
Schmitz A, Garg K, Koumaki D, Kuonen F, Lazić E, Verykiou S, Rübsam M.(2015)
Assessing the in vivo epidermal barrier in mice: dye penetration assays.
J Invest Dermatol. 2015 Feb;135(2):e29.Verykiou S, Ellis RA, Lovat PE.(2014)
Established and Emerging Biomarkers in Cutaneous Malignant Melanoma.
Healthcare (Basel). 2014 Jan 14;2(1):60-73.

 

COMMUNICATIONS

Verykiou S, Hill DS, Plummer R and Lovat PE (2017)Modulation of autophagy reduces survival of trametinib-resistant, CD271 expressing melanoma subpopulations. Accepted oral presentation British Society for Investigative Dermatology, Manchester, April 2017
Verykiou S, Rohman A, Bowler K, Plummer R, Lovat PE and Hill DS
Inhibition of autophagy reduces survival of trametinib-resistant, CD271 expressing melanoma subpopulations. Poster presentation Society for Melanoma Research, Boston USA, November 2016

Verykiou S, Hill DS, Plummer R and Lovat PE (2015)
Contribution of autophagy to the survival of melanoma-initiating CD271-positive subpopulations.Oral presentation at The British Society for Investigative Dermatology annual meeting, Southampton 2015

Verykiou S, Hill DS, Plummer R and Lovat PE (2015)
Contribution of autophagy to the survival of melanoma-initiating CD271-positive subpopulations. Oral presentation at The Royal Society of Medicine AbbVie Dermatology Trainee Research Prize meeting, Royal Society of Medicine, April 2015

Hill DS, Verykiou S, Robinson N, Armstrong J, Przyborski S, Chaudhry B, Lovat PE (2014)
Modelling melanoma metastasis using organotypic skin equivalent and zebrafish models.
Pig Cell and Mel Res: 27:6- 1236 Poster presentation Society for Melanoma Research, Zurich 2014

Verykiou S, Ellis RA, Lovat PE, Established and Emerging Biomarkers in Cutaneous Malignant
Melanoma, Healthcare 2014, 2(1), 60-73

Verykiou S, Ellis RA, Prajapati P, Lumsdon J, Ness T, Armstrong JA, Lovat PE, Kirkham N (2013)
Ambra-1 expression in the peri-tumoural epidermis is a prognostic biomarker in melanoma.
Journal of Investigative Dermatology Volume 133, P232. Poster presentation at The International Investigative Dermatology Meeting, Edinburgh, May 2013.

Hill DS*, Verykiou S*, Chaudhry B, Lovat PE
Modelling melanoma metastasis with 3D organotypic skin equivalents and zebra fish xenografts.
Submitted and accepted for presentation at The Society for Melanoma Research, Philadelphia, Nov 2013 (*Joint principle authors)

Ellis RA, Horswell S, Verykiou S, Ness T, Armstrong JL, Kirkham N, Lovat PE
Prognostic significance of autophagy biomarkers in the identification of high-risk melanomas.
Submitted and accepted for presentation at The Society for Melanoma Research, Philadelphia, Nov. 2013

Verykiou S, Oliphant TJ, Rahim RR, Lawrence CM, Langtry JA (2013),
Change in diagnosis following Mohs micrographic surgery.
British Journal of Dermatology 169 (Suppl. 1), p 68, pp66–85.
Oral presentation at The British Association of Dermatologists, Liverpool, July 2013

Verykiou S, Langtry JA, Rajan N (2012)
Cutaneous malignant melanoma: Does increased number of biopsies increase melanoma detection?
British Journal of Dermatology 167 (Suppl. 1), p48, pp77–99.
Poster presentation at The British Association of Dermatologists, Birmingham, July 2012

Associated Hospitals / Clinics

Specialties

  • DERMATOLOGIST-VENEREOLOGIST

Experience

  • Consultant dermatologist and Dermatologic surgeon, RVI  (Feb, 2019 - Current)

    Newcastle upon Tyne, UK

  • Post-CCT fellow in advanced dermatologic and Mohs surgery, RVI,  (Feb, 2018 - Feb, 2019)

    Newcastle upon Tyne, UK

  • ST6 dermatology RVI  (Jul, 2017 - Feb, 2018)

    Newcastle upon Tyne, UK

  • CRUK funded PhD student  (Jul, 2014 - Jul, 2017)

    Newcastle University, Newcastle upon Tyne

  • Academic Clinical Fellow Dermatology, RVI  (Aug, 2011 - Jul, 2014)

    Newcastle upon Tyne, UK

  • CT1/2 ST Helier Hospital, Royal Marsden Hospital  (Aug, 2009 - Aug, 2011)

    King’s College hospital London, UK

  • FY1/2 Princess Royal Hospital, Shropshire  (Aug, 2007 - Aug, 2009)

    West Midlands, UK Royal Shrewsbury Hospital, West Midlands, UK

  • Clinical attachment in “A.Sygros”  (Jan, 2007 - Jun, 2007)

    Dermartological hospital of Athens

  • Member of Board of Directors   (Dec, 2019 - Current)

    North Eastern Skin Research Fund

Education

  • Degree in Medicine (Ptychio Iatrikes)  ( - Dec, 2006)

    University of Patras, Greece

  • Postgraduate Diploma in Practical Dermatology  ( - Aug, 2010)

    University of Cardiff

  • MRCP UK  ( - Nov, 2010)

    London

  • Doctors as Educator Accreditation Royal College of Physicians  ( - Sep, 2011)

    London

  • Oct 2012: SCE Dermatology  

  • MSc in Clinical Research/Leadership, Distinction  (Sep, 2013 - Current)

    Newcastle University

  • MSc in Dermoscopy and preventive dermato-oncology,  (Oct, 2017 - Current)

    University of Graz,Austria

  • PhD  (Oct, 2017 - Current)

    Newcastle University

  • Masters in Clinical Research, Distinction  (Apr, 2020 - Current)

    Newcastle University

  • European Society for Dermatological Research/EADV Research Course: ‘Mouse models in skin research  (Jul, 2013 - Current)

    Cologne, Germany

  • BAD/THESIS course, British Association of Dermatologists,  (Jun, 2012 - Current)

    London

  • Postgraduate certificate in Clinical Research  (Apr, 2020 - Current)

    Newcastle University

  • Introduction to critical appraisal of qualitative research  (Mar, 2011 - Current)

    Newcastle University

  • Good Clinical Practice  (Oct, 2011 - Current)

    Newcastle University

Honours & Awards

  • €3960 travel bursary to visit the laboratory of Professor M. Piacentini, University of Rome. Funded by the fondation RENÉ TOURAINE  (January 1, 2016)

  • £17,800 clinical research bursary from CRUK  (April 6, 2020)

  • £250,000 Clinical research fellowship from CRUK  (April 6, 2020)

  • £5,794 project grant from The North Eastern Skin Research Fund  (April 6, 2020)

  • £500: British Association of Dermatologists  (November 1, 2015)

  • £500 : British Association of Dermatologists  (November 1, 2013)

  • £500: Research Taster Bursary, British Association of Dermatologists/NIHR  (March 1, 2013)

  • £500 : British Society for Investigative Dermatology(BSID)/Janssen Cilag  (May 1, 2013)

  • £200 : BSID/ THESIS  (June 1, 2012)

Photo Gallery

0  Review(s)

  • WE TAKE REVIEWS VERY SERIOUSLY AND DO NOT ALLOW ANY ABUSE. PLEASE PROVIDE ONLY TRUE INFORMATION. ANY ABUSIVE REVIEWS WILL NOT BE PUBLISHED.

Leave Your Review

Please Login To add Review